aod9604 clinical trials efficacy side effects fat loss AOD-9604 Peptide AOD-9604: The Fat-Loss Peptide —

It targets belly fat specifically while preserving muscle

Shaking the vial instead of gentle swirling damages peptide structure

Since the liver is the major site of IGF-1 production, when steatosis develops lowering insulin sensitivity, the severity of steatosis at different stages of insulin resistance and metabolic syndrome seems to be correlated with worsened circulating IGF-1 levels [234]

Variables such as body weight, calorie intake, energy expenditure, glucose, and fat oxidation, insulin, and glycerol were measured before and after treatment with AOD9604 and hGH

For long-term stability and consistency we still recommend refrigerated storage of the dry compound and protection from prolonged light exposure

Overview Product details